Several studies have shown that both hypertriglyceridemia and hypercholesteromia diminish glucose stimulated insulin secretion by inhibiting glucose oxidation via reducing pyruvate dehydrogenase (PDH) activity and elevating PDH kinase activity [33–36]. The gene discussed is PDP1; the disease is hypertriglyceridemia.